Veterinary Medicines Information website

NOBILIS RISMAVAC CONCENTRADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA POLLOS

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Download as PDF

Product identification

Medicine name:
NOBILIS RISMAVAC CONCENTRADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA POLLOS
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken (broiler)
  • Chicken (pullet for egg production, future layer)
  • Future breeder pullet
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    10.00
    50% cell culture infectious dose
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Suspension and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3334 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/06/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/06/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 21/06/2024
Download